Articles/ Views and analysis Big data enables the promise of personalised medicine Catherine 0 Comment As our personalised medicine month continues, Joel Haspel and Ketan Patel discuss big data and its role in Share X Big data enables the promise of personalised medicine https://pharmaphorum.com/views-and-analysis/big-data-enables-the-promise-of-personalised-medicine/
Articles/ Views and analysis Spotlight on… multiple sclerosis (MS) Catherine 0 Comment In our central nervous system disorders focus month, Andrea Lisher provides us with an overview of multiple sclerosis Share X Spotlight on… multiple sclerosis (MS) https://pharmaphorum.com/views-and-analysis/spotlight-on-multiple-sclerosis-ms/
Articles/ Views and analysis Pharma gets social: The future of social media in pharma Catherine 0 Comment This month, Daniel Ghinn shares his opinion on where he sees social media in pharma will be heading Share X Pharma gets social: The future of social media in pharma https://pharmaphorum.com/views-and-analysis/pharma-gets-social-the-future-of-social-media-in-pharma/
Articles/ Views and analysis Personalised medicine Catherine 0 Comment Anthony Rowbottom explores ‘the new modern era of medicine’ – ‘individual & personalised medicine’. If, like me, you Share X Personalised medicine https://pharmaphorum.com/views-and-analysis/personalised-medicine/
Articles/ Views and analysis How to enhance patient understanding of medical products Catherine 0 Comment Not every patient is up-to-date with the latest medical and technical terminology. In this article, Ashish Khera discusses Share X How to enhance patient understanding of medical products https://pharmaphorum.com/views-and-analysis/enhance-patient-understanding-of-medical-products/
Articles/ Views and analysis KOL perspectives: Dr Rajaram Ramadoss Catherine 0 Comment Dr. Ramadoss, consultant and Deputy Director of the Department of intensive care at Lyell McEwin Hospital, Australia, shares Share X KOL perspectives: Dr Rajaram Ramadoss https://pharmaphorum.com/views-and-analysis/syamala-ariyanchira-interviews-dr-rajaram-ramadoss/
Articles/ Views and analysis Is it time for pharma leaders to focus on positive social and patient impact as business drivers? Catherine 0 Comment Anup Soans questions whether it’s time for the industry to re-engage governments, civil society and other stakeholders and Share X Is it time for pharma leaders to focus on positive social and patient impact as business drivers? https://pharmaphorum.com/views-and-analysis/is-it-time-for-pharma-leaders-to-focus-on-positive-social-and-patient-impact-as-business-drivers/
Articles/ Views and analysis Physician perspectives: Matthew Katz Catherine 0 Comment Our October physician perspective comes from Matthew Katz, who shares his thoughts on social media within the healthcare Share X Physician perspectives: Matthew Katz https://pharmaphorum.com/views-and-analysis/physician-perspectives-matthew-katz/
Articles/ Views and analysis How can we reliably discover the biomarkers we need to achieve stratified medicine? Catherine 0 Comment The burgeoning field of stratified / personalised medicine is reliant upon assessing patients using accurate predictive biomarkers – Share X How can we reliably discover the biomarkers we need to achieve stratified medicine? https://pharmaphorum.com/views-and-analysis/how-can-we-reliably-discover-the-biomarkers-we-need-to-achieve-stratified-medicine/
